Imperial College London

ProfessorNicholasMazarakis

Faculty of MedicineDepartment of Brain Sciences

Chair MolBioMedicine and Head of Gene Therapy
 
 
 
//

Contact

 

+44 (0)20 7594 7024n.mazarakis Website

 
 
//

Assistant

 

Mrs Hadeel Abdeen +44 (0)20 7594 7014

 
//

Location

 

E402Burlington DanesHammersmith Campus

//

Summary

 

Summary

Professor Nicholas D. Mazarakis holds the Lucas-Lee chair of Molecular BioMedicine and is head of Gene Therapy in the Department of Brain Sciences, Faculty of Medicine, Imperial College London. He is a molecular neuroscientist with an international reputation in gene therapy of neurological diseases. He has served as Vice President of Neurobiology at Oxford BioMedica plc, where he pioneered the first ever lentiviral gene therapy to the clinic for Parkinson’s disease (ProSavin®). His research focuses on investigating molecular pathways of neurodegeneration and developing translational gene therapies for neurological diseases. He received his Ph.D. from King’s College University of London and is an elected fellow of the Society of Biology. He has lectured in conferences worldwide and published in top science journals such as Nature, Science and PNAS. His research is supported by several grants including an Advanced Investigators award in 2008 and a Proof of Concept grant in 2013 from the European Research Council.

 

Videos:

Imperial College wins seven European Research Council Advanced Grants

Researching more focused gene therapies for motor neurone diseases:


Academic Health Sciences Centre (AHSC)

Imperial wins AHSC accreditation:

Selected Publications

Journal Articles

Katsouri L, Lim YM, Blondrath K, et al., 2016, PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model, Proceedings of the National Academy of Sciences of the United States of America, Vol:113, ISSN:0027-8424, Pages:12292-12297

Eleftheriadou I, Trabalza A, Ellison SM, et al., 2014, Specific Retrograde Transduction of Spinal Motor Neurons using Lentiviral Vectors Targeted to Presynaptic NMJ Receptors, Molecular Therapy, Vol:22, ISSN:1525-0016, Pages:1285-1298

Hislop JN, Islam TA, Eleftheriadou I, et al., 2014, Rabies Virus Envelope Glycoprotein Targets Lentiviral Vectors to the Axonal Retrograde Pathway in Motor Neurons, Journal of Biological Chemistry, Vol:289, Pages:16148-16163

More Publications